Aalborg Universitets hospital

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Glioblastoma1 trial
• Lung cancer1 trial
• Mesothelioma1 trial
• Metastatic breast cancer1 trial
• Pancreatic cancer1 trial

Phase

• Phase 1/21 trial
• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• Eli Lilly and Company1 trial
• Incyte Corporation1 trial
• Orion Corporation, Orion Pharma1 trial

Running trials

• Recruiting

  A 2-part Phase 1/2 Open-label Trial on ODM-212

  NCT07563738· Phase 1/2· Orion Corporation, Orion Pharma· Source

  Contact: Weronika Szejniuk, MD

• Active, not recruiting

  A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer

  NCT02107703· Phase 3· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer1 recruiting
• Mesothelioma1 recruiting
• Pancreatic cancer1 recruiting

Closed trials

• Terminated

  Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations

  NCT05267106· Phase 2· Incyte Corporation· Source